Log in to your Inderes Free account to see all free content on this page.
Hamlet BioPharma
5.91 SEK
+1.20 %
Less than 1K followers
HAMLET B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hamlet BioPharma
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| growth-% | |||||||
| EBITDA | -17.1 | -22.8 | -7.5 | -17.1 | -20.0 | -32.9 | -44.7 |
| EBIT | -17.1 | -22.9 | -7.5 | -17.1 | -20.0 | -40.5 | -53.1 |
| Profit before taxes | -17.1 | -23.4 | -7.7 | -17.2 | -19.9 | -39.8 | -52.7 |
| Net income | -17.1 | -23.4 | -7.7 | -17.2 | -19.9 | -39.8 | -52.7 |
| EPS | -0.17 | -0.22 | -0.07 | -0.15 | -0.17 | -0.24 | -0.30 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | |||||||
| EBIT-% | |||||||
| ROE | -213.0 % | -223.7 % | -280.4 % | -45.3 % | -93.0 % | -59.5 % | -129.0 % |
| ROI | -151.5 % | -161.0 % | -60.6 % | -41.2 % | -68.8 % | -56.0 % | -109.5 % |
Login required
This content is only available for logged in users